[The price of self-paid influenza vaccines has generally rebounded, and the price of free vaccines has stabilized at around 9 yuan/tube] On October 11, reporters recently visited community health service centers in Shenzhen, Shanghai, and Nanjing and found that the number of appointments for some outpatient clinics was tight, but the vaccine inventory was relatively sufficient. In terms of price, the selected prices of some trivalent split vaccines in Shanghai range from 86.4 yuan to 96.4 yuan per dose. Self-funded influenza vaccines (non-immunization program) such as Hualan Vaccine, Changchun Biotech, Zhejiang Tianyuan, Fosun Yalifeng, and Beijing Sinovac have seen price increases to varying degrees; while the prices of some government procurement projects for key groups (immunization program vaccines) are still around 9 yuan/tube. An official from a head flu vaccine company told reporters that the company's production this year has increased significantly compared with previous years, and plans to exceed 25 million doses. However, due to the adjustment of virus strains, the batch release progress has been delayed compared with previous years. Xiaocai's note: In February 2026, the World Health Organization announced the recommended components of the northern hemisphere influenza vaccine for 2026-2027, and no longer included B/Yamagata viruses in the recommended formula. The vaccination guide for this epidemic season released by the Chinese Center for Disease Control and Prevention in September showed that the influenza vaccines on the market in China in 2026-2027 only include trivalent inactivated vaccines and trivalent live attenuated vaccines. (Reporters Lu Afeng and Yu Miao)